A unique collection of 182 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery;Bioactivity and safety confirmed by pre-clinical research and clinical trials, and most of them are approved to be marketed;Targets cover various cytokines including IL, CSF, IFN, TNF, TGF-beta family, growth factors, chemokine family, etc;Detailed compound information with structure, target, activity, IC50 value, and biological activity description;Structurally diverse, medicinally active, and cell permeable;NMR and HPLC validated to ensure high purity and quality;